Golden
Biomatics Capital Partners

Biomatics Capital Partners

Venture capital firm investing in companies at the intersection of health care and technology.

Biomatics Capital Partners is a venture capital firm based in Seattle, Washington, United States. The firm was established by Boris Nikolic and Julie Sunderland in 2016. Biomatics Capital Partners specializes in providing funds for companies operating in the healthcare, technology, and life science sectors. As of June 2019, the firm is managing an active portfolio of 15 companies and has sold off its stakes in three companies.

Timeline

Funded Companies

5 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

A Cambridge, MA - based startup that uses gene editing tech for xenotransplantation procedures in the medical industry.

BlackThorn Therapeutics is a San Francisco-based company.

Cytrellis Biosystems is a Woburn, Massachusetts-based company.

Associated investment funds

2 Results
Investment Fund
Investment Fund
Total offering (USD)
Total offering (USD)
Total sold (USD)
Total sold (USD)
Location
Location
Date signed
Date signed

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References